Targeting Ab Oligomers are protease-resistant and inhibit long-term potentiation. J Biol Chem 283: 16790–16800. 47. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14: 837–842. 48. Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R (2004) Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J Neurosci 24: 3370–3378. 49. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, et al. (2006) Early- onset behavioral and synaptic deficits in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A 103: 5161–5166. 50. Sudol KL, Mastrangelo MA, Narrow WC, Frazer ME, Levites YR, et al. (2009) Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer’s disease. Mol Ther 17: 2031–2040. 51. O’Nuallain B, Acero L, Williams AD, Koeppen HP, Weber A, et al. (2008) Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies. Biochemistry 47: 12254–12256. 52. O’Nuallain B, Williams AD, McWilliams-Koeppen HP, Acero L, Weber A, et al. Anti-amyloidogenic activity of IgGs contained in normal plasma. J Clin Immunol 30(Suppl 1): S37–42. 53. Dodel RC, Du Y, Depboylu C, Hampel H, Frolich L, et al. (2004) Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75: 1472–1474. 54. Dodel R, Neff F, Noelker C, Pul R, Du Y, et al. Intravenous immunoglobulins as a treatment for Alzheimer’s disease: rationale and current evidence. Drugs 70: 513–528. 55. Paul S, Planque S, Nishiyama Y () Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide. J Clin Immunol 30(Suppl 1): S43–49. PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e13928